| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/28/2007 | US7262299 Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse |
| 08/28/2007 | US7262296 Substituted aryl alkenoic acid heterocyclic amides |
| 08/28/2007 | US7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 08/28/2007 | US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts |
| 08/28/2007 | US7262199 Tyrosine kinase inhibitors |
| 08/28/2007 | US7262196 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/28/2007 | US7262195 Compounds useful as motilin agonists and method |
| 08/28/2007 | US7262192 Such as 1-(2-ethoxyethyl)-3-methyl-5-[(3R)-3-methylpiperazin-1-yl]-N-pyrimidin-4-yl-1H-pyrazolo[4,3-d]pyrimidin-7-amine; cyclic-guanosine monophosphate phosphodiesterase inhibitors |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/28/2007 | US7262186 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl0-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide |
| 08/23/2007 | WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | WO2007093904A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 08/23/2007 | WO2007093827A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 08/23/2007 | WO2007093540A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | WO2007093402A1 Pesticides containing a bicyclic bisamide structure |
| 08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007093328A1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 08/23/2007 | WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 08/23/2007 | WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 08/23/2007 | WO2007059257A3 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 08/23/2007 | WO2007029062A3 Novel pyridine derivatives |
| 08/23/2007 | US20070197794 Method for preparing pyrrolidine oximes |
| 08/23/2007 | US20070197788 Method for the preparation of enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases |
| 08/23/2007 | US20070197783 Compositions and methods of treating cell proliferation disorders |
| 08/23/2007 | US20070197782 N4-[2,2-Dimethyl-3-oxo-benzo[1,4]thiazin-6-yl]-5-fluoro-N2-(3-hydroxy-4,5-dimethoxyphenyl)-2,4-pyrimidinediamine;5-Fluoro-N2-(3-hydroxy-4,5-dimethoxyphenyl)-N4-[3-oxo-benzo[1,4]thiazin-6-yl]-2,4-pyrimidinediamine; autoimmune diseases |
| 08/23/2007 | US20070197775 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070197615 Process for the preparation of the PPAR alpha agonist NS-220 |
| 08/23/2007 | US20070197610 Benzisoxazoles |
| 08/23/2007 | US20070197605 2-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxymethyl)cyclohexylcarbamoyl]cyclobutanecarboxylic acid; modulation and control lipid and/or carbohydrate metabolism |
| 08/23/2007 | US20070197604 3-Methyl-6-(4-{5-methyl-4-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-oxazol-2-yl}-phenyl)-pyridazine; for treatment of obesity, cognitive deficiencies, narcolepsy |
| 08/23/2007 | US20070197595 Benzisoxazoles |
| 08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197541 Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same |
| 08/23/2007 | US20070197536 Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors |
| 08/23/2007 | US20070197532 Glucokinase activators |
| 08/23/2007 | US20070197531 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors |
| 08/23/2007 | US20070197530 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/23/2007 | US20070197529 Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
| 08/23/2007 | US20070197526 Pyrazoles for the treatment of obesity and other CNS disorders |
| 08/23/2007 | US20070197525 Novel tetracyclic tetrahydrofuran derivatives |
| 08/23/2007 | US20070197513 calcium channel modulator; [[1-(4-{2-[1-(4-Chloro-phenyl)-2-(2-methoxy-phenyl)-1H-imidazol-4-yl]-ethyl}-(4-fluoro-phenyl)-methyl-amine; analgesic, antidiabetic agent; angina, hypertension, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 08/23/2007 | US20070197509 Compositions and methods for modulating gated ion channels |
| 08/23/2007 | US20070197508 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 08/23/2007 | US20070197504 tert-butyl 4-{[3-({[(6-methyl-3-pyridyl)amino]carbonylamino}methyl)phenyl]methyl}-piperazinecarboxylate; selectively modulates the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure |
| 08/23/2007 | US20070197492 Modulation of Pathogenicity |
| 08/23/2007 | US20070197472 N-Alkynyl-2-Heteroaryloxyalkylamides For Use As Fungicides |
| 08/23/2007 | US20070197393 Tricyclic benzoylpyrazole derivatives |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | DE102006007146A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 08/23/2007 | CA2642406A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 08/23/2007 | CA2641933A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 08/23/2007 | CA2641734A1 Acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/23/2007 | CA2640807A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 08/23/2007 | CA2640307A1 Pesticides containing a bicyclic bisamide structure |
| 08/23/2007 | CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2618628A1 Triazole compounds that modulate hsp90 activity |
| 08/22/2007 | EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 08/22/2007 | EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1819701A1 Cyclic iminocarbamates and use thereof |
| 08/22/2007 | EP1819700A2 Potassium salt of an hiv intergrase inhibitor |
| 08/22/2007 | EP1819699A2 Diazepine oxazolidinones as antibacterial agents |
| 08/22/2007 | EP1819690A2 Chroman compounds |
| 08/22/2007 | EP1819683A2 Potassium salt of an hiv integrase inhibitor |
| 08/22/2007 | EP1819341A2 Il-12 modulatory compounds |
| 08/22/2007 | EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 08/22/2007 | EP1379513B1 Prodrugs of cox-2 inhibitors |
| 08/22/2007 | EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 08/22/2007 | CN101023074A Inhibitors of the interaction between MDM2 and P53 |
| 08/22/2007 | CN101023063A Azine-carboxamides as anti-cancer agent |
| 08/21/2007 | US7259263 Method of synthesis of azole-containing amino acids |
| 08/21/2007 | US7259262 Arylazole derivatives, their manufacture and use as pharmaceutical agents |
| 08/21/2007 | US7259250 C-nitroso compounds and use thereof |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259177 Containing an oxazole ring 2-phenyl-, furanyl- or thiophenyl-substituted; e.g., 2,2-Dimethyl-4-[3-(5-methyl-2-p-tolyloxazol-4-ylmethoxy)cyclohexyl]-butyric acid; treating disorders of fatty acid metabolism, glucose utilization disorders, and also of disorders in which insulin resistance is involvolved |
| 08/21/2007 | US7259175 Alkanoic acids substituted with a group containing pyridinyl-, pyrimidinyl- or pyrazinyl-phenyl linked through a thiazolyl- or oxazolyl- phenyl group; e.g., 3-[4-(2-{2-[6-(2-Fluoro-phenyl)-pyridin-3-yl]-5-methyl-thiazol-4-yl}-ethoxy)-2-methyl-phenyl]-propionic acid; treating diabetes and atherosclerosis |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | US7259161 For therapy of immune response, an autoimmune disease, a neurodegenerative, or a solid or hematologic malignancy |
| 08/21/2007 | US7259158 Naphthaline derivatives as H3 inverse agonists |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/21/2007 | US7259155 Phosphonic diester derivatives |
| 08/21/2007 | US7259154 Pyrrolopyrimidines |
| 08/21/2007 | CA2397270C Method for the preparation of 5-cyanophthalide |
| 08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 08/16/2007 | WO2007092751A2 Compounds and methods for modulating fx-receptors |
| 08/16/2007 | WO2007092531A2 Compounds and compositions as protein kinase inhibitors |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091147A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 08/16/2007 | WO2007091046A1 Chemical compounds |
| 08/16/2007 | WO2007076460A3 Substituted thiazole ureas useful as inhibitors of protein kinases |